Abstract:Andrographolide (ADG) is a diterpenoid isolated from Andrographis paniculata with a wide spectrum of biological activities, including anti-inflammatory, anticancer and hepatoprotective effects. However, its poor water solubility and efflux by P-glycoprotein have resulted in lower bioavailability. In this study, ADG nanosuspensions (ADG-NS) were prepared using a wet media milling technique followed by freeze drying. d-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS), a surfactant that inhibits P-glycoprotein function, and sodium lauryl sulfate were used as surface stabilizers. A Box-Behnken design was used to optimize the nanosuspension preparation. The products of these optimal preparation conditions were amorphous and possessed much faster dissolution in vitro than a coarse powder of ADG. The particle size and redispersibility index of the freeze-dried ADG-NS were 244.6±3.0 nm and 113%±1.14% (n=3), respectively. A short-term stability study indicated that the freeze-dried ADG-NS could remain highly stable as nanosuspensions during the testing period. A test of transport across a Caco-2 cell monolayer revealed that the membrane permeability (Papp) of ADG-NS was significantly higher than the permeability of the ADG coarse powder or ADG-NS without TPGS (P<0.01). Compared to the ADG coarse powder, a physical mixture, commercial dripping pills and ADG-NS without TPGS, ADG-NS exhibited significantly higher plasma exposure with significant enhancements in Cmax and area under the curve of plasma concentration versus time from zero to the last sampling time (AUC0-t ) (P<0.01). An evaluation of the anti-inflammatory effect on Carr-induced paw edema demonstrated that the ADG-NS were more effective in reducing the rate of paw swelling, producing a greater increase in the serum levels of nitric oxide (NO), Interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) (P<0.01) and an increase in superoxide dismutase activity (P<0.05) compared to the ADG coarse powder. This study indicated that nanosuspensions could act as an effective delivery device for ADG to enhance its oral bioavailability and biological efficacy.

Optimization of Andrographolide Solid Lipid Nanoparticles by Central Composite Design and Response Surface Methodology

Optimization of Fabrication Parameters to Prepare Tea Catechin-Loaded Liposomes Using Response Surface Methodology

Response surface methodology for the optimization of lactoferrin nano-liposomes

Optimising the Shell Thickness-To-Radius Ratio for the Fabrication of Oil-Encapsulated Polymeric Microspheres

Development of andrographolide-loaded solid lipid nanoparticles for lymphatic targeting: Formulation, optimization, characterization, in vitro, and in vivo evaluation

Study on the Optimal Formulation and Preparation Conditions of Propranolol-loaded Transfersomes by Central Composite Design and Response Surface Method

Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design

Integrated computer-aided formulation design: A case study of andrographolide/ cyclodextrin ternary formulation

Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate

Optimization of preparation of DHAQ-loaded PEG-PLGA-PEG nonaparticles using central composite design

Optimization of the Preparation Techniques of Floxuridinyl Diacetate Solid Lipid Nanoparticles by Orthogonal Test

Optimization of solid lipid nanoparticles of silymarin by using Box-Behnken experimental design

Preparation and Optimization on Minoxidil Nanostructured Lipid Carriers

Optimization of Epirubicin Liposome Formulation Using Box-Behnken Experimental Design

Optimizing Supercritical Anti-solvent Preparation of Curcumin-Loaded PLGA Nanoparticles by Response Surface Methodology

Development and optimization of osmotically controlled asymmetric membrane capsules for delivery of solid dispersion of lycopene

Application of Rotatable Central Composite Design in the Preparation and Optimization of Poly (Lactic-Co-glycolic Acid) Nanoparticles for Controlled Delivery of HSA

Development of a Curcumin-Loaded Lecithin/Chitosan Nanoparticle Utilizing a Box-Behnken Design of Experiment: Formulation Design and Influence of Process Parameters

High Drug Capacity of Nano-Levodopa-Liposomes: Preparation, In Vitro Release and Brain-Targeted Research

Optimization of Solid Lipid Nanoparticles of Ezetimibe in Combination with Simvastatin Using Quality by Design (QbD)

Preparation and pharmacodynamic evaluation of sodium aescinate solid lipid nanoparticles